Thomas O Daniel

Title: Thomas O Daniel: Innovator in Angiogenesis Research

Introduction

Thomas O Daniel is a prominent inventor based in Nashville, TN (US). He has made significant contributions to the field of biomedical research, particularly in the modulation of angiogenesis. With a total of 3 patents to his name, his work has the potential to impact various therapeutic approaches.

Latest Patents

One of his latest patents focuses on the modulation of endothelial cell surface receptor activity in the regulation of angiogenesis. This method involves administering a composition that modulates ECRTP/DEP-1 activity in a vertebrate subject. The composition may include a monoclonal antibody that preferentially binds to ECRTP/DEP-1, thereby influencing angiogenesis. Another notable patent provides methods for screening EphB receptors or their binding ligands to promote selected biological activities when in multimeric form. This invention also outlines methods for initiating, promoting, directing, or inhibiting biological activities involving EphB receptors.

Career Highlights

Thomas O Daniel is affiliated with Vanderbilt University, where he conducts his research and development. His work is characterized by a strong focus on innovative methods that can lead to advancements in medical treatments.

Collaborations

He collaborates with esteemed colleagues such as Takamune Takahashi and Elke Stein, contributing to a dynamic research environment that fosters innovation.

Conclusion

Thomas O Daniel's contributions to the field of angiogenesis research exemplify the impact of innovative thinking in biomedical science. His patents and collaborative efforts continue to pave the way for future advancements in this critical area of study.